retatrutide efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Efficacy of GLP-1 analog peptides,

Studies of biomarkers (amyloid PET, tau imaging, MRI volumetrics) to detect early structural/functional changes

Starting with easily digestible foods and gradually incorporating a wider variety of permitted foods is recommended

Local mechanisms controlling blood flow include acute and chronic vasoconstriction and dilatation and changes in the tissue vasculature, with endothelial autocrine secretions playing an important role in vasoconstriction and vasodilation

It is my theory that increasing dermal IGF-1 levels can help to overcome receptor and pathway mutations by increasing the rate of signaling, promoting more consistent keratinocyte differentiation and maturation, while in parallel also stimulating sebocyte proliferation through 5-Reductase and inhibiting inflammation via stimulation of IL-10 production

A high clinical suspicion is needed when urine organic acids analysis is not available